#CARdiovascular
The only thing Michael Tracey should fight is cardiovascular disease.
October 6, 2026 at 2:50 PM
I've watched this for a decade and I'm still not numb, which my doctor says is either a moral achievement or a cardiovascular event; either way, the punchline was dead queers. #trans #transrights #lgbtq #queernews #politics #news #journalism #democracy […]

[Original post on thistlenfern.org]
October 6, 2026 at 2:39 PM
I've watched this for a decade and I'm still not numb, which my doctor says is either a moral achievement or a cardiovascular event; either way, the punchline was dead queers. #Trans #TransRights #LGBTQ #QueerNews #Politics #News #Journalism #Democracy thistleandmoss.com/p...
October 6, 2026 at 2:39 PM
...a "normal" LDL and still be carrying meaningfully elevated particle-level risk (Sniderman et al., meta-analysis of LDL-C, non-HDL-C, and apoB as cardiovascular risk markers, published in Circulation: Cardiovascular Quality and Outcomes, 2011).
October 6, 2026 at 2:32 PM
A large meta-analysis pooling over 233,000 people found that when LDL-C and ApoB disagree, ApoB is the stronger predictor of cardiovascular risk...meaning someone can have...
October 6, 2026 at 2:32 PM
Lilly’s Oral GLP-1 Foundayo Meets Cardiovascular Safety Endpoints

Eli Lilly’s oral GLP-1 drug, Foundayo (orforglipron), met primary cardiovascular safety endpoints in the Phase 3 ACHIE…

Read more: https://embers.news/article/lillys-oral-glp-1-foundayo-meets-cardiovascular-safety-endpoints-342496
Lilly’s Oral GLP-1 Foundayo Meets Cardiovascular Safety Endpoints
Eli Lilly’s oral GLP-1 drug, Foundayo (orforglipron), met primary cardiovascular safety endpoints in the Phase 3 ACHIEVE-4 clinical trial. It demonstrated non-inferiority to insulin glargine while reducing A1C levels and body weight.
embers.news
October 6, 2026 at 2:11 PM
Uncovering the Incredible Benefits of EDTA Chelation Therapy share.google/9DgnRM1bqCom.... ("Natural Health Cures are The Best Methods for Your Body Mind and Soul during Fall 🍁🍂!")
Uncovering the Incredible Benefits of EDTA Chelation Therapy
Learn the benefits of EDTA chelation therapy and how it safely removes damaging metals and enhances cardiovascular, cognitive, metabolic, and energy health.
share.google
October 6, 2026 at 1:58 PM
If it persists, I'm sure someone will evaluate its impact on consumption, cholesterol & cardiovascular events, maybe even production and GHG emissions.
But from a health and environmental standpoint, it's reasonable to predict this may be an unintended benefit (as with bombing Iran for renewables).
October 6, 2026 at 1:40 PM
""
And it can get gummed up by low-grade inflammation and stymied by poor cardiovascular health, which contributes to poor brain health.
""
October 6, 2026 at 1:22 PM
The story of alcohol consumption continues to be mixed with moderate levels of consumption being linked with lower rates of both mortality and Major Adverse Cardiovascular Events, though higher rates of certain cancers ajcn.nutrition.org/article/S000...
Association of self-reported alcohol consumption compared with abstention with major adverse cardiovascular events, cancer, and mortality among United States veterans: a cohort study from the Million ...
Alcohol consumption is a common behavior among United States veterans, yet its impact on long-term health outcomes remains incompletely understood.
ajcn.nutrition.org
October 6, 2026 at 12:45 PM
Economic evaluation of SGLT2 inhibitors and GLP-1 receptor agonists in Thai patients with type 2 diabetes and established atherosclerotic cardiovascular disease
Economic evaluation of SGLT2 inhibitors and GLP-1 receptor agonists in Thai patients with type 2 diabetes and established atherosclerotic cardiovascular disease
chuckyscarnage.tech.blog
October 6, 2026 at 12:34 PM
Fantastic morning at #SYExpo2026! YHARC research showcased:
• Eloise Carruthers (Cardiovascular & SMI)
• Dr Natalie Jones (VICTOR)
• Dr Michael McCooe (Secure Data Environments)
🔗 Agenda: www.syinnovationhub.net/events/
October 6, 2026 at 12:20 PM
🫀 #ArtículoDelMes: el grupo de Jorge Alegre-Cebollada (CNIC) muestra en Nature Cardiovascular Research que el mavacamten frena la miocardiopatía hipertrófica por MYBPC3, sea cual sea la mutación 👇
https://sebbm.es/articulo-del-mes/
October 6, 2026 at 12:02 PM
Best way to improve and maintain cardiovascular (and overall) health? 🫀

🔸Eat healthily (whole foods plant-based diets) 🌱

Second close best is to exercise regularly 💪🏻

#PlantBased #LifeExpectancy #HeartDisease #heart #corazón #longevity #diet #ItsTheDiet #EatClean #MedSky #CardiovasculaDisease
October 6, 2026 at 11:53 AM
Living Better

From floating saunas to clinical trials: How heat might help mental health

www.npr.org/2026/10/05/n...
From floating saunas to clinical trials: How heat might help mental health
While scientists have a decent understanding of how sauna and other forms of heat exposure exercises our cardiovascular system, they know relatively little about its impact on mental health.
www.npr.org
October 6, 2026 at 11:36 AM
He aguantado hoy haciendo treinta minutos de ejercicio cardiovascular. Ahora me falta acondicionar la bicicleta estática que tengo y que no utilizo 🚲☺️
October 6, 2026 at 11:26 AM
Olmesartan Medoxomil Market Size, Trends & Growth by 2034

According to The Insight Partners, The global olmesartan medoxomil market size is projected to reach US$ 2.38 billion by 2034 from US$ 1.61 billion in 2025. The market is anticipated to register a CAGR of 4.40% during the forecast period…
Olmesartan Medoxomil Market Size, Trends & Growth by 2034
According to The Insight Partners, The global olmesartan medoxomil market size is projected to reach US$ 2.38 billion by 2034 from US$ 1.61 billion in 2025. The market is anticipated to register a CAGR of 4.40% during the forecast period 2026-2034. The Olmesartan Medoxomil Market is witnessing consistent expansion owing to the rising prevalence of hypertension and cardiovascular diseases worldwide.
www.news24.ph
October 6, 2026 at 11:17 AM
In just 25 days, the global cardiovascular community will gather in San Diego for 4 days of breakthrough science, innovation, and collaboration at #TCT2026

Don't miss the world's premier forum for #interventionalcardiology 👉 Register today: https://ow.ly/GJej50ZUHov

#CardioSky
October 6, 2026 at 11:00 AM